Jounce Therapeutics (JNCE) Earnings
|
Expand Research on JNCE
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +53.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +4.9% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/10/23 | Q123 | N/A | -$0.68 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/9/23 | Q422 | N/A | $0.04 | N/A | N/A | $37.33M | N/A | N/A | N/A | ||
| 3/13/23 | Q422 | N/A | -$0.09 | N/A | N/A | $48.5M | N/A | N/A | N/A | ||
| 3/20/23 | Q422 | N/A | -$0.06 | N/A | N/A | $82M | N/A | N/A | N/A | ||
| 3/27/23 | Q422 | N/A | -$0.06 | N/A | N/A | $82M | N/A | N/A | N/A | ||
| 11/10/22 | Q322 | -$0.60 | -$0.62 | +$0.02 | N/A | $2.5M | N/A |  | | Details | |
| 8/4/22 | Q222 | -$0.08 | -$0.68 | +$0.60 | $25.37M | $950K | N/A | | | Details | |
| 3/6/19 | Q418 | -$0.06 | -$0.36 | +$0.30 | $20.1M | $12.63M | = | | | Details |
